Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial

BACKGROUND: Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial glucose control. This study compared the pharmacokinetics, glucodynamics, safety, and tolerability of URLi and Humalog(®) in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Linnebjerg, Helle, Zhang, Qianyi, LaBell, Elizabeth, Dellva, Mary Anne, Coutant, David E., Hövelmann, Ulrike, Plum-Mörschel, Leona, Herbrand, Theresa, Leohr, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716921/
https://www.ncbi.nlm.nih.gov/pubmed/32468447
http://dx.doi.org/10.1007/s40262-020-00903-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716921/
https://www.ncbi.nlm.nih.gov/pubmed/32468447
http://dx.doi.org/10.1007/s40262-020-00903-0

Ejemplares similares